excedrin pm triple action caplets
Generic: acetaminophen, aspirin (nsaid) and diphenhydramine citrate
Labeler: haleon us holdings llcDrug Facts
Product Profile
Brand Name
excedrin pm triple action caplets
Generic Name
acetaminophen, aspirin (nsaid) and diphenhydramine citrate
Labeler
haleon us holdings llc
Dosage Form
TABLET, COATED
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, diphenhydramine citrate 38 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0067-2056
Product ID
0067-2056_8304e801-1a21-42b1-ad99-dd8621be478a
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2014-09-24
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00672056
Hyphenated Format
0067-2056
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
excedrin pm triple action caplets (source: ndc)
Generic Name
acetaminophen, aspirin (nsaid) and diphenhydramine citrate (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 38 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (0067-2056-91) / 100 TABLET, COATED in 1 BOTTLE
Packages (2)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8304e801-1a21-42b1-ad99-dd8621be478a", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["362O9ITL9D", "R16CO5Y76E", "4OD433S209"], "rxcui": ["1593110", "1593116"], "spl_set_id": ["b3812d27-40af-40d7-864a-dfa4ae34cb9e"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE", "package_ndc": "0067-2056-24", "marketing_start_date": "20140924"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2056-91) / 100 TABLET, COATED in 1 BOTTLE", "package_ndc": "0067-2056-91", "marketing_start_date": "20140924"}], "brand_name": "Excedrin PM Triple Action Caplets", "product_id": "0067-2056_8304e801-1a21-42b1-ad99-dd8621be478a", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0067-2056", "generic_name": "Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Excedrin PM Triple Action Caplets", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "DIPHENHYDRAMINE CITRATE", "strength": "38 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20140924", "listing_expiration_date": "20261231"}